Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

21.4%

3 terminated/withdrawn out of 14 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

30%

3 of 10 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 1
6(46.2%)
Phase 2
6(46.2%)
N/A
1(7.7%)
13Total
Phase 1(6)
Phase 2(6)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT03309111Phase 1Completed

Study of ISB 1342, a CD38/CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma

Role: collaborator

NCT05146206Completed

Patient Satisfaction and Sensory Attributes Allergic Rhinitis Nasal Spray

Role: collaborator

NCT03568162Phase 2Completed

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

Role: collaborator

NCT05286944Not ApplicableUnknown

Mobile Phone Daily Alarm To Improve Compliance Of Intranasal Corticosteroid Among Allergic Rhinitis Patients.

Role: collaborator

NCT03983395Phase 1Terminated

Study of ISB 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer

Role: collaborator

NCT02829372Phase 1Terminated

Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers

Role: collaborator

NCT02683928Phase 2Completed

To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis

Role: collaborator

NCT02235727Phase 1Completed

Safety and Tolerability of GBR 900 in a Single Ascending Dose Study in Healthy Subjects

Role: collaborator

NCT02361034Phase 1Completed

To Evaluate Safety, Tolerability and Pharmacokinetics of GRC 27864 in Healthy Subjects and Elderly Healthy Subjects

Role: lead

NCT02179645Phase 1Completed

GRC 27864 First in Man, Single Ascending Dose Study in Healthy Volunteers

Role: collaborator

NCT01726413Phase 2Completed

A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients).

Role: collaborator

NCT01436890Phase 2Completed

A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma

Role: collaborator

NCT01430507Phase 2Completed

A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis

Role: collaborator

NCT01556152Phase 2Withdrawn

A Clinical Trial to Study the Effects of GRC 17536 in Patients With Painful Diabetic Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients)

Role: collaborator

All 14 trials loaded